National Triglyceride Alliance Celebrates One Year of Impact and Recognizes National Triglycerides Day [Yahoo! Finance]
Why Ionis Pharmaceuticals' (IONS) 2026 Catalyst Pipeline Supported Leerink's Higher Target [Yahoo! Finance]
Ionis Pharmaceuticals, Inc. (IONS) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]
Ionis announces changes to Board of Directors
Ionis Pharmaceuticals (IONS) had its price target raised by Leerink Partners from $102.00 to $104.00. They now have an "outperform" rating on the stock.